Drug · DIN 02339277
RECOTHROM
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since May 29, 2025; first marketed March 24, 2010.
- Drug Identification Number (DIN)
- 02339277
- Company (DIN owner)
- Baxter CorporationMississauga, Ontario, Canada
- Schedule
- Schedule D
- Dosage form
- Powder For Solution
- Route
- Topical
- Therapeutic class (ATC)
- Thrombin B02BD30
- Class
- Human
- Record last updated
- June 9, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| THROMBIN ALFA | 6000 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 4, 2019: NOC 21691New Drug Submission (NDS) · administrative - change in product ownership
- March 6, 2018: NOC 20648New Drug Submission (NDS) · Transfer of Drug Identification Numbers (DINs) and labelling updates
- May 26, 2016: NOC 18131New Drug Submission (NDS) · Transfer of din ownership
- February 7, 2014: NOC 15212New Drug Submission (NDS) · Transfer of drug identification numbers
- December 15, 2009: NOC 10867New Drug Submission (NDS)
Other DINs named RECOTHROM
- DIN 02339285 · Cancelled Pre Market